No Data
No Data
Shareholders in BGI Genomics (SZSE:300676) Are in the Red If They Invested Three Years Ago
Investing in stocks inevitably means buying into some companies that perform poorly. But the last three years have been particularly tough on longer term BGI Genomics Co., Ltd. (SZSE:300676) sharehol
Huada Gene (300676.SZ): BRCA1/2 gene mutation detection kit (combined with probe-anchored polymerization sequencing) registration terminated
Huada Gene (300676.SZ) announced that Huada Biotechnology (Wuhan) Co., Ltd., a wholly-owned subsidiary of the company (simplified...
Ronglian Technology (002642.SZ): The company participated in the construction of BGI related projects in the early stages
Gelonghui, May 17 | Ronglian Technology (002642.SZ) said on the investor interactive platform that as a professional digital service provider, the company has been deeply involved in the biomedical industry for more than ten years, focusing on the deep integration and innovative application of biotechnology and information technology, and has the ability to integrate internal and external resources and technical advantages to provide customers with specialized solutions. It mainly provides information technology products and services to clinical hospitals, scientific research institutions, biomedical companies and institutions of higher learning. The company participated in the construction of BGI Genomics related projects in the early stages.
BGI-HL OHA Lab Inaugurated in Harbin, Initiating Colorectal Cancer Risk Assessment for 800,000
SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated in Harbin, Heilongjian
There May Be Reason For Hope In BGI Genomics' (SZSE:300676) Disappointing Earnings
Shareholders appeared unconcerned with BGI Genomics Co., Ltd.'s (SZSE:300676) lackluster earnings report last week. Our analysis suggests that while the profits are soft, the foundations of the busin
BGI Genomics Co., Ltd.'s (SZSE:300676) Business And Shares Still Trailing The Industry
You may think that with a price-to-sales (or "P/S") ratio of 3.8x BGI Genomics Co., Ltd. (SZSE:300676) is a stock worth checking out, seeing as almost half of all the Biotechs companies in China have
No Data